Yasutoshi Takashima, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bacteroides fragilis | 1 | 2024 | 238 | 0.820 |
Why?
|
CpG Islands | 2 | 2024 | 1221 | 0.820 |
Why?
|
Metalloendopeptidases | 1 | 2024 | 393 | 0.790 |
Why?
|
Kidney Glomerulus | 3 | 2016 | 568 | 0.630 |
Why?
|
Colorectal Neoplasms | 7 | 2024 | 6852 | 0.540 |
Why?
|
Sulfatases | 1 | 2016 | 44 | 0.530 |
Why?
|
Sulfotransferases | 1 | 2016 | 149 | 0.490 |
Why?
|
Receptors, Growth Factor | 1 | 2016 | 326 | 0.480 |
Why?
|
Heparitin Sulfate | 1 | 2016 | 224 | 0.480 |
Why?
|
Alkaline Phosphatase | 1 | 2017 | 865 | 0.460 |
Why?
|
Immunoglobulins | 1 | 2017 | 859 | 0.450 |
Why?
|
DNA Methylation | 2 | 2024 | 4373 | 0.420 |
Why?
|
Diabetic Nephropathies | 2 | 2017 | 973 | 0.400 |
Why?
|
Cell Adhesion Molecules | 1 | 2017 | 1600 | 0.370 |
Why?
|
Podocytes | 4 | 2015 | 402 | 0.350 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2016 | 1651 | 0.330 |
Why?
|
Glomerulosclerosis, Focal Segmental | 3 | 2015 | 325 | 0.270 |
Why?
|
Sarcoma | 1 | 2017 | 1785 | 0.260 |
Why?
|
Microsatellite Instability | 3 | 2024 | 715 | 0.260 |
Why?
|
Carcinoma | 1 | 2017 | 2330 | 0.260 |
Why?
|
Bacteroides Infections | 1 | 2024 | 89 | 0.230 |
Why?
|
Keloid | 1 | 2022 | 54 | 0.190 |
Why?
|
Carcinoma, Large Cell | 1 | 2021 | 113 | 0.180 |
Why?
|
Epithelial Cells | 3 | 2017 | 3665 | 0.160 |
Why?
|
Natural Killer T-Cells | 1 | 2021 | 311 | 0.160 |
Why?
|
Nephrosclerosis | 1 | 2017 | 11 | 0.150 |
Why?
|
Bacterial Toxins | 1 | 2024 | 931 | 0.150 |
Why?
|
Transcription Factors | 1 | 2017 | 12096 | 0.140 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2024 | 2053 | 0.140 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2021 | 346 | 0.140 |
Why?
|
Nephritis, Interstitial | 1 | 2018 | 154 | 0.140 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2022 | 1086 | 0.140 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2024 | 1725 | 0.130 |
Why?
|
Smad Proteins, Receptor-Regulated | 1 | 2016 | 8 | 0.130 |
Why?
|
Kidney Tubules | 1 | 2017 | 449 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2021 | 989 | 0.130 |
Why?
|
Foam Cells | 1 | 2015 | 68 | 0.120 |
Why?
|
Receptors, Urokinase Plasminogen Activator | 1 | 2015 | 75 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2016 | 255 | 0.120 |
Why?
|
Tissue Culture Techniques | 1 | 2016 | 290 | 0.120 |
Why?
|
Integrin beta Chains | 1 | 2015 | 115 | 0.120 |
Why?
|
Lipid Peroxidation | 1 | 2015 | 271 | 0.120 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2015 | 278 | 0.110 |
Why?
|
Signal Transduction | 2 | 2017 | 23341 | 0.110 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2016 | 614 | 0.110 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2021 | 8506 | 0.110 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2017 | 487 | 0.110 |
Why?
|
Phenotype | 2 | 2024 | 16534 | 0.100 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2017 | 730 | 0.100 |
Why?
|
Osteoblasts | 1 | 2017 | 1142 | 0.100 |
Why?
|
Mutation | 3 | 2024 | 29915 | 0.090 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2021 | 2872 | 0.090 |
Why?
|
Endocytosis | 1 | 2015 | 958 | 0.090 |
Why?
|
Receptor, Notch1 | 1 | 2013 | 495 | 0.090 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2016 | 1111 | 0.080 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2024 | 895 | 0.080 |
Why?
|
Agrochemicals | 1 | 2008 | 10 | 0.080 |
Why?
|
Streptomycin | 1 | 2008 | 70 | 0.080 |
Why?
|
Cell Differentiation | 2 | 2017 | 11471 | 0.080 |
Why?
|
Transforming Growth Factor beta | 1 | 2016 | 1957 | 0.080 |
Why?
|
Rivers | 1 | 2008 | 64 | 0.070 |
Why?
|
Stomach Neoplasms | 1 | 2018 | 1422 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2016 | 2443 | 0.070 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2008 | 266 | 0.070 |
Why?
|
Membrane Proteins | 2 | 2021 | 7843 | 0.070 |
Why?
|
Peptide Fragments | 1 | 2017 | 5098 | 0.060 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2016 | 3480 | 0.060 |
Why?
|
Phosphorylation | 1 | 2016 | 8297 | 0.060 |
Why?
|
Apoptosis | 2 | 2017 | 9468 | 0.060 |
Why?
|
Aged | 6 | 2024 | 168217 | 0.060 |
Why?
|
Mice, Knockout | 2 | 2016 | 14354 | 0.060 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2017 | 2239 | 0.050 |
Why?
|
Exotoxins | 2 | 2013 | 121 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 5246 | 0.050 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 2 | 2013 | 305 | 0.050 |
Why?
|
Prognosis | 4 | 2024 | 29558 | 0.050 |
Why?
|
Middle Aged | 5 | 2024 | 219560 | 0.050 |
Why?
|
Mice, Inbred C57BL | 2 | 2016 | 22006 | 0.040 |
Why?
|
Humans | 15 | 2024 | 758381 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2024 | 58681 | 0.040 |
Why?
|
Tumor Microenvironment | 2 | 2022 | 3840 | 0.040 |
Why?
|
Adult | 3 | 2024 | 219916 | 0.040 |
Why?
|
Prospective Studies | 4 | 2024 | 54136 | 0.040 |
Why?
|
Blood Urea Nitrogen | 1 | 2017 | 186 | 0.040 |
Why?
|
Female | 6 | 2024 | 390316 | 0.040 |
Why?
|
Male | 5 | 2024 | 358742 | 0.040 |
Why?
|
Cell Line | 3 | 2017 | 15594 | 0.030 |
Why?
|
Bacteria | 1 | 2008 | 2199 | 0.030 |
Why?
|
Time Factors | 2 | 2016 | 39873 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2021 | 13245 | 0.030 |
Why?
|
Mesangial Cells | 1 | 2015 | 23 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2021 | 1113 | 0.030 |
Why?
|
Animals | 6 | 2017 | 167777 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 17768 | 0.030 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 2015 | 325 | 0.030 |
Why?
|
PAX2 Transcription Factor | 1 | 2013 | 86 | 0.030 |
Why?
|
Dibenzazepines | 1 | 2013 | 26 | 0.030 |
Why?
|
Paired Box Transcription Factors | 1 | 2013 | 206 | 0.030 |
Why?
|
WT1 Proteins | 1 | 2013 | 184 | 0.030 |
Why?
|
Receptors, LDL | 1 | 2015 | 485 | 0.030 |
Why?
|
Sialoglycoproteins | 1 | 2013 | 315 | 0.030 |
Why?
|
Disease-Free Survival | 1 | 2023 | 6821 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2021 | 2201 | 0.030 |
Why?
|
Cell Movement | 2 | 2015 | 5201 | 0.020 |
Why?
|
Creatinine | 1 | 2017 | 1892 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2021 | 2858 | 0.020 |
Why?
|
Rabbits | 1 | 2017 | 4771 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2017 | 1404 | 0.020 |
Why?
|
Mice, Transgenic | 2 | 2013 | 9518 | 0.020 |
Why?
|
Integrases | 1 | 2013 | 516 | 0.020 |
Why?
|
Down-Regulation | 1 | 2017 | 2905 | 0.020 |
Why?
|
Random Allocation | 1 | 2015 | 2385 | 0.020 |
Why?
|
Proteinuria | 1 | 2013 | 594 | 0.020 |
Why?
|
Hyperplasia | 1 | 2013 | 1154 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2008 | 7403 | 0.020 |
Why?
|
RNA, Untranslated | 1 | 2013 | 459 | 0.020 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2013 | 607 | 0.020 |
Why?
|
Epithelium | 1 | 2013 | 1605 | 0.020 |
Why?
|
Patient Selection | 1 | 2021 | 4244 | 0.020 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2013 | 620 | 0.020 |
Why?
|
Calcium-Binding Proteins | 1 | 2013 | 1066 | 0.020 |
Why?
|
Heparin | 1 | 2015 | 1632 | 0.020 |
Why?
|
Genetic Markers | 1 | 2013 | 2608 | 0.020 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2008 | 763 | 0.020 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 1136 | 0.020 |
Why?
|
Antibodies, Monoclonal | 2 | 2013 | 9160 | 0.020 |
Why?
|
Up-Regulation | 1 | 2015 | 4114 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2015 | 18125 | 0.020 |
Why?
|
Diet | 1 | 2022 | 8003 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2013 | 2413 | 0.010 |
Why?
|
Mice | 3 | 2015 | 81107 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2013 | 3709 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2022 | 39060 | 0.010 |
Why?
|
Thrombosis | 1 | 2015 | 2929 | 0.010 |
Why?
|
Disease Progression | 1 | 2017 | 13468 | 0.010 |
Why?
|
Drug Resistance, Bacterial | 1 | 2008 | 1055 | 0.010 |
Why?
|
Macrophages | 1 | 2015 | 5737 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2013 | 10417 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 11894 | 0.010 |
Why?
|